These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32684101)

  • 1. Dysfunction of adaptive immunity is related to severity of COVID-19: a retrospective study.
    Xie L; Wu Q; Lin Q; Liu X; Lin W; Hao S; Hu W; Xiang G; Lu H; Li S
    Ther Adv Respir Dis; 2020; 14():1753466620942129. PubMed ID: 32684101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal immunity of non-survivors with COVID-19: predictors for mortality.
    Zhao Y; Nie HX; Hu K; Wu XJ; Zhang YT; Wang MM; Wang T; Zheng ZS; Li XC; Zeng SL
    Infect Dis Poverty; 2020 Aug; 9(1):108. PubMed ID: 32746940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppressed T cell-mediated immunity in patients with COVID-19: A clinical retrospective study in Wuhan, China.
    Xu B; Fan CY; Wang AL; Zou YL; Yu YH; He C; Xia WG; Zhang JX; Miao Q
    J Infect; 2020 Jul; 81(1):e51-e60. PubMed ID: 32315725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The laboratory tests and host immunity of COVID-19 patients with different severity of illness.
    Wang F; Hou H; Luo Y; Tang G; Wu S; Huang M; Liu W; Zhu Y; Lin Q; Mao L; Fang M; Zhang H; Sun Z
    JCI Insight; 2020 May; 5(10):. PubMed ID: 32324595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.
    Wu H; Zhu H; Yuan C; Yao C; Luo W; Shen X; Wang J; Shao J; Xiang Y
    JAMA Netw Open; 2020 Jun; 3(6):e2010895. PubMed ID: 32492165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and immunological features of severe and moderate coronavirus disease 2019.
    Chen G; Wu D; Guo W; Cao Y; Huang D; Wang H; Wang T; Zhang X; Chen H; Yu H; Zhang X; Zhang M; Wu S; Song J; Chen T; Han M; Li S; Luo X; Zhao J; Ning Q
    J Clin Invest; 2020 May; 130(5):2620-2629. PubMed ID: 32217835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher level of neutrophil-to-lymphocyte is associated with severe COVID-19.
    Kong M; Zhang H; Cao X; Mao X; Lu Z
    Epidemiol Infect; 2020 Jul; 148():e139. PubMed ID: 32641174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19.
    Hou H; Zhang B; Huang H; Luo Y; Wu S; Tang G; Liu W; Mao L; Mao L; Wang F; Sun Z
    Clin Exp Immunol; 2020 Jul; 201(1):76-84. PubMed ID: 32365221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China.
    Qin C; Zhou L; Hu Z; Zhang S; Yang S; Tao Y; Xie C; Ma K; Shang K; Wang W; Tian DS
    Clin Infect Dis; 2020 Jul; 71(15):762-768. PubMed ID: 32161940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-Cell Subset Counts in Peripheral Blood Can Be Used as Discriminatory Biomarkers for Diagnosis and Severity Prediction of Coronavirus Disease 2019.
    Jiang M; Guo Y; Luo Q; Huang Z; Zhao R; Liu S; Le A; Li J; Wan L
    J Infect Dis; 2020 Jun; 222(2):198-202. PubMed ID: 32379887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China.
    Fu J; Kong J; Wang W; Wu M; Yao L; Wang Z; Jin J; Wu D; Yu X
    Thromb Res; 2020 Aug; 192():3-8. PubMed ID: 32407937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormalities of peripheral blood system in patients with COVID-19 in Wenzhou, China.
    Sun S; Cai X; Wang H; He G; Lin Y; Lu B; Chen C; Pan Y; Hu X
    Clin Chim Acta; 2020 Aug; 507():174-180. PubMed ID: 32339487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships among lymphocyte subsets, cytokines, and the pulmonary inflammation index in coronavirus (COVID-19) infected patients.
    Wan S; Yi Q; Fan S; Lv J; Zhang X; Guo L; Lang C; Xiao Q; Xiao K; Yi Z; Qiang M; Xiang J; Zhang B; Chen Y; Gao C
    Br J Haematol; 2020 May; 189(3):428-437. PubMed ID: 32297671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive role of clinical features in patients with coronavirus disease 2019 for severe disease.
    Mo J; Liu J; Wu S; LÜ A; Xiao L; Chen D; Zhou Y; Liang L; Liu X; Zhao J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):536-541. PubMed ID: 32879103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of clinical characteristics and laboratory findings of 95 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a retrospective analysis.
    Zhang G; Zhang J; Wang B; Zhu X; Wang Q; Qiu S
    Respir Res; 2020 Mar; 21(1):74. PubMed ID: 32216803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased circulating level of interleukin-6 and CD8
    Yang PH; Ding YB; Xu Z; Pu R; Li P; Yan J; Liu JL; Meng FP; Huang L; Shi L; Jiang TJ; Qin EQ; Zhao M; Zhang DW; Zhao P; Yu LX; Wang ZH; Hong ZX; Xiao ZH; Xi Q; Zhao DX; Yu P; Zhu CZ; Chen Z; Zhang SG; Ji JS; Wang FS; Cao GW
    Infect Dis Poverty; 2020 Nov; 9(1):161. PubMed ID: 33239109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics of 71 patients with coronavirus disease 2019.
    Xiao M; Hou M; Liu X; Li Z; Zhao Q
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Jul; 45(7):790-796. PubMed ID: 32879082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou, China.
    Tan M; Liu Y; Zhou R; Deng X; Li F; Liang K; Shi Y
    Immunology; 2020 Jul; 160(3):261-268. PubMed ID: 32460357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Retrospective Study of the C-Reactive Protein to Lymphocyte Ratio and Disease Severity in 108 Patients with Early COVID-19 Pneumonia from January to March 2020 in Wuhan, China.
    Yang M; Chen X; Xu Y
    Med Sci Monit; 2020 Sep; 26():e926393. PubMed ID: 32914767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced numbers of T cells and B cells correlates with persistent SARS-CoV-2 presence in non-severe COVID-19 patients.
    Liu B; Han J; Cheng X; Yu L; Zhang L; Wang W; Ni L; Wei C; Huang Y; Cheng Z
    Sci Rep; 2020 Oct; 10(1):17718. PubMed ID: 33077873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.